{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:20:54Z","timestamp":1790914854836,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":5260,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.fertnstert.2007.02.002","type":"journal-article","created":{"date-parts":[[2007,4,27]],"date-time":"2007-04-27T07:13:42Z","timestamp":1177658022000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":363,"title":["The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study"],"prefix":"10.1016","volume":"89","author":[{"given":"Lawrence","family":"Engmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"DiLuigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Nulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Benadiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2007.02.002_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmg005","article-title":"Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)","volume":"9","author":"Delvigne","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/humrep\/14.9.2181","article-title":"An \u201cepidemic\u201d of severe OHSS: a price we have to pay?","volume":"14","author":"Abramov","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib4","unstructured":"Department of Health and Human Services, Centers for Disease Control. 2003 Assisted reproductive technology (ART) report: section 5\u2014trends in ART, 1996\u20132004. Available at: http:\/\/www.cdc.gov\/ART2004\/Section5.htm"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1471-0528.1993.tb12981.x","article-title":"Assisted conception using buserelin and human menopausal gonadotrophins in women with polycystic ovary syndrome","volume":"100","author":"Wada","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/oxfordjournals.humrep.a138260","article-title":"The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features","volume":"8","author":"Delvigne","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/oxfordjournals.humrep.a137702","article-title":"In-vitro fertilization and the ovarian hyperstimulation syndrome","volume":"7","author":"MacDougall","year":"1992","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/humrep\/14.1.167","article-title":"The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology","volume":"14","author":"Engmann","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib9","first-page":"611","article-title":"Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review","volume":"84","author":"Tummon","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib10","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/humrep\/12.11.2359","article-title":"Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients","volume":"12","author":"Damario","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0015-0282(16)60906-8","article-title":"Disappearance of exogenously administered human chorionic gonadotropin","volume":"52","author":"Damewood","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib13","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/humrep\/15.9.1965","volume":"15","author":"Itskovitz-Eldor","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1023\/A:1026498629324","article-title":"Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran\/Antagon) to prevent a premature LH surge: a case report","volume":"18","author":"De Jong","year":"2001","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"Kol","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib17","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib18","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/humrep\/dei190","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Engmann","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","article-title":"CONSORT (Consolidated Standards of Reporting Trials) Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration","volume":"134","author":"Altman","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.fertnstert.2004.03.055","article-title":"Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization","volume":"82","author":"Schmidt","year":"2004","journal-title":"Fert Steril"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF01133388","article-title":"A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality","volume":"3","author":"Cummins","year":"1986","journal-title":"J In Vitro Fert Embryo Transf"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/PL00007479","article-title":"Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction","volume":"264","author":"Ludwig","year":"2000","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib25","first-page":"84","article-title":"Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study","volume":"50","author":"Bahceci","year":"2005","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","article-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles","volume":"85","author":"Papanikolaou","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib27","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/humrep\/dei475","article-title":"Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial","volume":"21","author":"Babayof","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0015-0282(16)46932-3","article-title":"The diagnosis of ovarian hyperstimulation (OHS): the impact of ultrasound","volume":"39","author":"McArdle","year":"1983","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","article-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization","volume":"87","author":"Fauser","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib30","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1210\/jc.2002-021953","volume":"88","author":"Beckers","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/287145a0","article-title":"Gonadotropin releasing hormone agonists stimulate meiotic maturation of follicle-enclosed rat oocytes in vitro","volume":"287","author":"Hillensjo","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib32","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1210\/endo-108-5-2022","article-title":"Gonadotropin releasing hormone agonists stimulate oocyte meiosis and ovulation in hypophysectomized rats","volume":"108","author":"Ekholm","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib33","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1095\/biolreprod43.6.1012","article-title":"Effects of gonadotropin-releasing hormone agonists on meiotic maturation of follicle-enclosed oocytes in rabbits","volume":"43","author":"Yoshimura","year":"1990","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/09513598909152302","article-title":"LH surge induction by GnRH agonist at the time of ovulation","volume":"3","author":"Lanzone","year":"1989","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmi045","article-title":"GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis","volume":"12","author":"Griesinger","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0015-0282(01)02961-2","article-title":"Luteal phase support","volume":"77","author":"Penzias","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib37","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/humrep\/17.9.2287","article-title":"Luteal phase support in infertility treatment: a meta-analysis of the randomized trials","volume":"17","author":"Pritts","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004830","article-title":"Luteal phase support in assisted reproduction cycles","author":"Daya","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib39","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0015-0282(03)00177-8","article-title":"Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin","volume":"79","author":"Nevo","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.02.002_bib40","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.fertnstert.2005.07.214","article-title":"A\u00a0prospective randomized trial evaluating the effect of luteal phase estradiol supplementation on the success of IVF treatment","volume":"84","author":"Engmann","year":"2005","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502820700338X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502820700338X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:22:26Z","timestamp":1758007346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001502820700338X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S001502820700338X"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.02.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1145167.602311","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1145167.4083054","asserted-by":"object"}]},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}